Orchestra BioMed Holdings, Inc. (OBIO)

Orchestra BioMed Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	23.32	30.56	19.78	9.94	20.34
Short-Term Investments	51.71	57.04	64	0.96	15.45
Cash & Cash Equivalents	75.04	87.6	83.79	10.9	35.79
Cash Growth	-41.02%	4.55%	668.95%	-69.56%	-
Receivables	0.07	0.1	0.1	0.12	0.17
Inventory	0.12	0.15	0.28	0.07	0.07
Other Current Assets	1.21	1.27	0.53	0.23	0.23
Total Current Assets	76.43	89.11	84.69	11.32	36.25
Property, Plant & Equipment	2.81	2.83	3.68	1.12	1.03
Long-Term Investments	2.5	2.5	2.5	0.4	0.19
Other Long-Term Assets	0.89	0.77	4.71	0.69	0.63
Total Long-Term Assets	6.2	6.1	10.88	2.21	1.84
Total Assets	82.63	95.21	95.57	13.53	38.09
Accounts Payable	3.35	2.9	3.97	2.03	1.77
Deferred Revenue	16.94	17.43	19.54	22.4	20.93
Current Debt	0.47	0.65	0.7	2	4
Other Current Liabilities	-10.34	-9.77	-5.64	-14.19	-12.34
Total Current Liabilities	10.42	11.21	18.57	12.24	14.36
Long-Term Debt	1.16	1.04	11.17	3.67	5.46
Other Long-Term Liabilities	13.87	14.92	13.3	17.39	15.36
Total Long-Term Liabilities	15.02	15.96	24.47	21.07	20.82
Total Liabilities	25.44	27.17	43.04	33.31	35.18
Total Debt	1.62	1.69	11.87	5.67	9.46
Debt Growth	-86.16%	-85.79%	109.24%	-40.01%	-
Retained Earnings	-262.32	-248.85	-199.73	-166.13	-143.11
Comprehensive Income	-0.01	-0.01	-0.01	0	-0
Shareholders' Equity	57.19	68.04	52.53	-19.78	-48.54
Net Cash / Debt	73.41	85.91	71.92	5.22	26.33
Net Cash / Debt Growth	-36.44%	19.46%	1276.89%	-80.17%	-
Net Cash Per Share	2.05	2.59	4.80	0.59	13.08
Working Capital	66.01	77.91	66.12	-0.92	21.89
Book Value Per Share	1.60	2.05	3.50	-2.24	-24.11

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).